UniProt ID | DPOD2_HUMAN | |
---|---|---|
UniProt AC | P49005 | |
Protein Name | DNA polymerase delta subunit 2 | |
Gene Name | POLD2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 469 | |
Subcellular Localization | Nucleus . Recruited to DNA damage sites within 2 hours following UV irradiation. | |
Protein Description | As a component of the trimeric and tetrameric DNA polymerase delta complexes (Pol-delta3 and Pol-delta4, respectively), plays a role in high fidelity genome replication, including in lagging strand synthesis, and repair. [PubMed: 12403614] | |
Protein Sequence | MFSEQAAQRAHTLLSPPSANNATFARVPVATYTNSSQPFRLGERSFSRQYAHIYATRLIQMRPFLENRAQQHWGSGVGVKKLCELQPEEKCCVVGTLFKAMPLQPSILREVSEEHNLLPQPPRSKYIHPDDELVLEDELQRIKLKGTIDVSKLVTGTVLAVFGSVRDDGKFLVEDYCFADLAPQKPAPPLDTDRFVLLVSGLGLGGGGGESLLGTQLLVDVVTGQLGDEGEQCSAAHVSRVILAGNLLSHSTQSRDSINKAKYLTKKTQAASVEAVKMLDEILLQLSASVPVDVMPGEFDPTNYTLPQQPLHPCMFPLATAYSTLQLVTNPYQATIDGVRFLGTSGQNVSDIFRYSSMEDHLEILEWTLRVRHISPTAPDTLGCYPFYKTDPFIFPECPHVYFCGNTPSFGSKIIRGPEDQTVLLVTVPDFSATQTACLVNLRSLACQPISFSGFGAEDDDLGGLGLGP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MFSEQAAQ -------CCCHHHHH | 8.22 | 22223895 | |
12 | Phosphorylation | QAAQRAHTLLSPPSA HHHHHHHHHCCCCCC | 28.54 | 30266825 | |
15 | O-linked_Glycosylation | QRAHTLLSPPSANNA HHHHHHCCCCCCCCC | 37.57 | 30059200 | |
15 | Phosphorylation | QRAHTLLSPPSANNA HHHHHHCCCCCCCCC | 37.57 | 30266825 | |
18 | Phosphorylation | HTLLSPPSANNATFA HHHCCCCCCCCCCEE | 47.19 | 30266825 | |
23 | Phosphorylation | PPSANNATFARVPVA CCCCCCCCEEEEEEE | 21.68 | 29396449 | |
31 | Phosphorylation | FARVPVATYTNSSQP EEEEEEEEECCCCCC | 30.98 | 21945579 | |
32 | Phosphorylation | ARVPVATYTNSSQPF EEEEEEEECCCCCCC | 8.32 | 21945579 | |
33 | Phosphorylation | RVPVATYTNSSQPFR EEEEEEECCCCCCCC | 25.03 | 21945579 | |
35 | Phosphorylation | PVATYTNSSQPFRLG EEEEECCCCCCCCCC | 23.66 | 28555341 | |
36 | Phosphorylation | VATYTNSSQPFRLGE EEEECCCCCCCCCCC | 43.90 | 21945579 | |
45 | Phosphorylation | PFRLGERSFSRQYAH CCCCCCCCHHHHHHH | 24.22 | 24719451 | |
47 | Phosphorylation | RLGERSFSRQYAHIY CCCCCCHHHHHHHHH | 21.52 | 17081983 | |
50 | Phosphorylation | ERSFSRQYAHIYATR CCCHHHHHHHHHHHH | 10.07 | 20068231 | |
53 | Phosphorylation | FSRQYAHIYATRLIQ HHHHHHHHHHHHHHH | 1.58 | - | |
68 | Phosphorylation | MRPFLENRAQQHWGS HHHHHCHHHHHHCCC | 25.13 | - | |
75 | Phosphorylation | RAQQHWGSGVGVKKL HHHHHCCCCCCHHHH | 25.72 | 22210691 | |
80 | Acetylation | WGSGVGVKKLCELQP CCCCCCHHHHHHCCC | 33.81 | 25953088 | |
80 | Phosphorylation | WGSGVGVKKLCELQP CCCCCCHHHHHHCCC | 33.81 | - | |
80 | Ubiquitination | WGSGVGVKKLCELQP CCCCCCHHHHHHCCC | 33.81 | 21906983 | |
81 | Ubiquitination | GSGVGVKKLCELQPE CCCCCHHHHHHCCCH | 56.83 | - | |
82 | Phosphorylation | SGVGVKKLCELQPEE CCCCHHHHHHCCCHH | 1.97 | - | |
90 | Ubiquitination | CELQPEEKCCVVGTL HHCCCHHCEEEEEHH | 31.13 | - | |
99 | Ubiquitination | CVVGTLFKAMPLQPS EEEEHHHHHCCCCHH | 47.06 | - | |
106 | Phosphorylation | KAMPLQPSILREVSE HHCCCCHHHHHHHHH | 22.69 | 21964256 | |
110 | Phosphorylation | LQPSILREVSEEHNL CCHHHHHHHHHHCCC | 47.12 | - | |
112 | Phosphorylation | PSILREVSEEHNLLP HHHHHHHHHHCCCCC | 32.30 | 20873877 | |
115 | Ubiquitination | LREVSEEHNLLPQPP HHHHHHHCCCCCCCC | 26.62 | - | |
116 | Ubiquitination | REVSEEHNLLPQPPR HHHHHHCCCCCCCCC | 46.70 | - | |
125 | Acetylation | LPQPPRSKYIHPDDE CCCCCCHHCCCCCCC | 49.88 | 25953088 | |
125 | Ubiquitination | LPQPPRSKYIHPDDE CCCCCCHHCCCCCCC | 49.88 | 21906983 | |
134 | Ubiquitination | IHPDDELVLEDELQR CCCCCCEECHHHHHH | 5.31 | - | |
145 | Ubiquitination | ELQRIKLKGTIDVSK HHHHHCCCCEECHHH | 49.35 | 21906983 | |
147 | Phosphorylation | QRIKLKGTIDVSKLV HHHCCCCEECHHHCC | 16.65 | 20068231 | |
151 | Phosphorylation | LKGTIDVSKLVTGTV CCCEECHHHCCCCCE | 19.27 | 20068231 | |
155 | Phosphorylation | IDVSKLVTGTVLAVF ECHHHCCCCCEEEEE | 37.26 | 20068231 | |
157 | Phosphorylation | VSKLVTGTVLAVFGS HHHCCCCCEEEEECE | 11.72 | 20068231 | |
160 | Ubiquitination | LVTGTVLAVFGSVRD CCCCCEEEEECEECC | 7.11 | - | |
164 | Phosphorylation | TVLAVFGSVRDDGKF CEEEEECEECCCCCE | 11.52 | 20068231 | |
178 | Ubiquitination | FLVEDYCFADLAPQK EEEEEEEECCCCCCC | 4.89 | - | |
180 | Ubiquitination | VEDYCFADLAPQKPA EEEEEECCCCCCCCC | 24.10 | - | |
182 | Phosphorylation | DYCFADLAPQKPAPP EEEECCCCCCCCCCC | 12.67 | 20068231 | |
186 | Phosphorylation | ADLAPQKPAPPLDTD CCCCCCCCCCCCCCC | 44.76 | 20068231 | |
192 | Phosphorylation | KPAPPLDTDRFVLLV CCCCCCCCCCEEEEE | 36.44 | 20068231 | |
220 | Ubiquitination | LGTQLLVDVVTGQLG HHHHEEEEECCCCCC | 29.19 | - | |
249 | Phosphorylation | ILAGNLLSHSTQSRD HHHHHHHCCCCCCHH | 20.68 | 30108239 | |
251 | Phosphorylation | AGNLLSHSTQSRDSI HHHHHCCCCCCHHHH | 25.43 | 30108239 | |
252 | Phosphorylation | GNLLSHSTQSRDSIN HHHHCCCCCCHHHHH | 25.74 | 30108239 | |
254 | Phosphorylation | LLSHSTQSRDSINKA HHCCCCCCHHHHHHH | 37.84 | 30108239 | |
257 | Phosphorylation | HSTQSRDSINKAKYL CCCCCHHHHHHHHHH | 27.27 | 26055452 | |
263 | Phosphorylation | DSINKAKYLTKKTQA HHHHHHHHHCHHHHC | 25.18 | - | |
265 | Phosphorylation | INKAKYLTKKTQAAS HHHHHHHCHHHHCCH | 27.66 | - | |
267 | Ubiquitination | KAKYLTKKTQAASVE HHHHHCHHHHCCHHH | 40.40 | 21906983 | |
267 | Ubiquitination | KAKYLTKKTQAASVE HHHHHCHHHHCCHHH | 40.40 | 21906983 | |
268 | Phosphorylation | AKYLTKKTQAASVEA HHHHCHHHHCCHHHH | 25.62 | 29457462 | |
272 | Phosphorylation | TKKTQAASVEAVKML CHHHHCCHHHHHHHH | 24.41 | 29457462 | |
286 | Phosphorylation | LDEILLQLSASVPVD HHHHHHHHHCCCCCC | 4.69 | 27251275 | |
292 | Phosphorylation | QLSASVPVDVMPGEF HHHCCCCCCCCCCCC | 8.97 | 20068231 | |
298 | Phosphorylation | PVDVMPGEFDPTNYT CCCCCCCCCCCCCCC | 40.79 | - | |
300 | Phosphorylation | DVMPGEFDPTNYTLP CCCCCCCCCCCCCCC | 44.82 | - | |
302 | Ubiquitination | MPGEFDPTNYTLPQQ CCCCCCCCCCCCCCC | 42.58 | - | |
345 | Phosphorylation | GVRFLGTSGQNVSDI CEEEECCCCCCHHHH | 36.26 | 20068231 | |
384 | Glutathionylation | TAPDTLGCYPFYKTD CCCCCCCCCCCCCCC | 4.36 | 22555962 | |
389 | Ubiquitination | LGCYPFYKTDPFIFP CCCCCCCCCCCCCCC | 46.99 | - | |
413 | Ubiquitination | NTPSFGSKIIRGPED CCCCCCCCCCCCCCC | 42.40 | - | |
424 | Ubiquitination | GPEDQTVLLVTVPDF CCCCCEEEEEECCCC | 3.46 | - | |
448 | Ubiquitination | NLRSLACQPISFSGF HHHHHCCEECCCCCC | 32.52 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
33 | T | Phosphorylation | Kinase | MAP3K7 | O43318 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DPOD2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DPOD2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PCNA_HUMAN | PCNA | physical | 11986310 | |
DPOD1_HUMAN | POLD1 | physical | 16510448 | |
DPOD4_HUMAN | POLD4 | physical | 16510448 | |
SOX12_HUMAN | SOX12 | physical | 21988832 | |
OSBL9_HUMAN | OSBPL9 | physical | 26344197 | |
DPOA2_HUMAN | POLA2 | physical | 26344197 | |
POLH_HUMAN | POLH | physical | 25662213 | |
REV3L_HUMAN | REV3L | physical | 28514442 | |
DPOD4_HUMAN | POLD4 | physical | 28514442 | |
DPOD1_HUMAN | POLD1 | physical | 28514442 | |
DPOD3_HUMAN | POLD3 | physical | 28514442 | |
PPP5_HUMAN | PPP5C | physical | 28514442 | |
P4HA2_HUMAN | P4HA2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. |